Pharmaceuticals

Global Methenamine Hippurate Tablets Market Size Projected to Reach $13.47 Billion During the Forecast Period

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Methenamine Hippurate Tablets Market Expected To Expand Between 2025 And 2029?

The methenamine hippurate tablets market has shown significant expansion in recent years. Its valuation is expected to rise from $9.52 billion in 2024 to $10.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%. The past growth in this market can be linked to factors such as its application in traditional UTI treatment, increasing worries about antibiotic resistance, strong clinical validation, established physician prescription patterns, and patients favoring non-antibiotic alternatives.

The methenamine hippurate tablets market is expected to experience robust expansion over the next few years. It is projected to reach $13.47 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. This projected growth throughout the forecast period is attributable to the increasing UTI prevalence, rising antibiotic resistance concerns, advancements in UTI management, a healthcare focus on preventive therapies, and ongoing clinical trials and research. Significant trends anticipated for the forecast period include an increased UTI incidence, a rise in antibiotic resistance, a growing preference for non-antibiotic treatments, an intensified focus on preventive healthcare, and continued research and development.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

What Are The Key Drivers Of Growth In The Methenamine Hippurate Tablets Market?

The methenamine hippurate tablets market is projected to experience growth in the future, driven by an expanding geriatric population. This demographic refers to individuals who are 60 years and above. Elderly patients are more prone to urinary tract infections due to various factors like reduced urine flow, an enlarged prostate, or kidney stones, making methenamine hippurate tablets necessary for addressing these conditions. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, by 2030, one in six people globally will be 60 or older. In 2022, the number of individuals over the age of 60 stood at 1.4 billion. The worldwide population of those aged 60 years or more is expected to double by 2050, reaching 2.1 billion. Furthermore, the number of people aged 80 years or older is anticipated to treble, amounting to 426 million. Consequently, the increasing geriatric population is fueling the expansion of the methenamine hippurate tablets market.

What Are The Major Segments Identified In The Methenamine Hippurate Tablets Market?

The methenamine hippurate tablets market covered in this report is segmented –

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs

4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:

1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options

2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

What Are The Major Trends Driving The Growth Of The Methenamine Hippurate Tablets Market?

Product innovation has emerged as a significant trend gaining traction within the methenamine hippurate tablets market. Key companies operating in this market are introducing innovative products to bolster their presence. For example, in May 2023, EQL Pharma, a European pharmaceutical firm focused on cost-effective generic and niche generic medicines for pharmacies and hospitals, announced an out-licensing agreement for Memprex (methenamine hippurate) with Laboratoires Majorelle. This agreement aims for distribution in the French market, thereby increasing its accessibility and offering a non-antibiotic choice for preventing UTIs. Laboratoires Majorelle, a leading women’s health company in France, will market and distribute Memprex, providing a non-antibiotic option for preventing urinary tract infections.

Which Key Market Players Are Investing In Expansion And Innovation Of Methenamine Hippurate Tablets Market?

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Methenamine Hippurate Tablets Market?

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Methenamine Hippurate Tablets Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9412&type=smp

Browse Through More Reports Similar to the Global Methenamine Hippurate Tablets Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Cough And Cold Preparations Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

Smart Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795